Omnicell, Inc. ( OMCL) - Key Metrics
OMCL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $6.87 | $0.53 | $1.53 | $1.33 |
| 2026Q1 | $6.84 | $0.25 | $1.20 | $0.93 |
| 2025Q4 | $6.98 | -$0.05 | $0.68 | $0.45 |
| 2025Q3 | $6.82 | $0.12 | $0.62 | $0.41 |
| 2025Q2 | $6.21 | $0.12 | $0.91 | $0.66 |
OMCL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 19.58 |
| 2026Q1 | 0% | 33.38 |
| 2025Q4 | 0% | -251.11 |
| 2025Q3 | 0% | 63.44 |
| 2025Q2 | 0% | 61.25 |
OMCL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.21% | 0% |
| 2026Q1 | 2.78% | 0% |
| 2025Q4 | 0.99% | 0% |
| 2025Q3 | 1.34% | 0% |
| 2025Q2 | 2.25% | 0% |
OMCL
Price: $32.79
52 week price:
Earnings Per Share: 0.83 USD
P/E Ratio: 44.76
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 358300
Ebitda: 28.6 millionMarket Capitalization: 1.6 billion